For decades, scientists had been searching for a vaccine that could fend off RSV and reduce the chance of extreme illness. A breakthrough finally came in 2013 when researchers identified a protein ...

The fact that the new RSV vaccination is being offered to people aged 75 to 79, but not to those over 80, has received a stronger response from Saga Magazine readers than any other issue we've covered ...

Experts worry that the unenthusiastic embrace of vaccines could spark outbreaks and increased hospitalizations.

Respiratory syncytial virus, or RSV, is something many parents know as a cause of bronchiolitis, but others may not have heard of it until recently. RSV causes infections of the lungs and ...

with an increased risk for severe RSV had ever received an RSV vaccine. There was variation seen in coverage by jurisdiction and demographic characteristics, with younger adults and those without ...

COVID-19 and respiratory syncytial virus (RSV) vaccines this fall in older adults. Uptake was lowest among younger adults and in people who didn’t have health insurance, the data showed.

Vaccines against both viruses, however, have been difficult to design. Now, Scripps Research scientists have analyzed the structure and stability of a critical RSV and hMPV protein to better ...

Vaccines against both viruses, however, have been difficult to design. Now, scientists have analyzed the structure and stability of a critical RSV and hMPV protein to better design vaccines that ...

"RSV in an older, frail adult is more likely to cause more morbidity and mortality than flu or COVID-19 in that age group. This is a big thing, and now we have vaccines for them," Jacobson said.